Skip to content
Lina Olsson, CEO HiloProbe

Image -

Lina Olsson, CEO HiloProbe

Lina Olsson, CEO of HiloProbe
Patrick Trädgårdh
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By:
Patrick Trädgårdh
File format:
.jpg
Size:
5568 x 3712, 2.06 MB
Download

Topics

Categories

Contacts

Tomas Ruuth

Tomas Ruuth

Press contact Head of PR & Communications PR & Communications 072-4024697 www.ubi.se

Related content

"The results promising and we look forward to the publication of the study" says Lina Olsson, CEO of Umeå based HiloProbe.

New promising data with ColoNode for colon cancer

Umeå University has in collaboration with HiloProbe AB completed the first part of a new clinical study of its ColoNode biomarker test, which provides further important evidence for the product ColoNode's benefits and usefulness in colon cancer.

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden